Lj. Sim-selley et al., Mu and kappa(1) opioid-stimulated [S-35]guanylyl-5 '-O-(gamma-thio)-triphosphate binding in cynomolgus monkey brain, NEUROSCIENC, 94(2), 1999, pp. 651-662
Agonist-stimulated [S-35]GTP gamma S binding allows the visualization of re
ceptor-activated G-proteins, thus revealing the anatomical localization of
functional receptor activity. Ln the present study, agonist-stimulated [S-3
5]GTP gamma S binding was used to demonstrate mu and kappa(1) opioid-stimul
ated [S-35]GTP gamma S binding in tissue sections and membranes from cynomo
lgus monkey brain using DAMGO and U50,488H, respectively. Concentrations of
agonists required to produce maximal stimulation of [S-35]GTP gamma S bind
ing were determined in membranes from the frontal poles of the brain. Recep
tor specificity was verified in both membranes and sections by inhibiting a
gonist-stimulated [S-35]GTP gamma S binding with the appropriate antagonist
. Mu opioid-stimulated [S-35]GTP gamma S binding was high in areas includin
g the amygdala, ventral striatum, caudate, putamen, medial thalamus and hyp
othalamus. Dense mu-stimulated [S-35]GTP gamma S binding was also found in
brainstem nuclei including the interpeduncular nucleus, parabrachial nucleu
s and nucleus of the solitary tract. Kappa(1) opioid-stimulated [S-35]GTP g
amma S binding was high in limbic and association cortex, ventral striatum,
caudate, putamen, globus pallidus, claustrum, amygdala, hypothalamus and s
ubstantia nigra.
These results demonstrate the applicability of [S-35]GTP gamma S autoradiog
raphy to examine receptor-activated G-proteins in the primate brain and rev
eal functional mu and kappa(1) opioid receptor activity that may contribute
to the reported central nervous system effects of opiates. (C) 1999 IBRO.
Published by Elsevier Science Ltd.